The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, the company said in a statement.
Learn more details here.
Now you can see non-English news...
2020-11-17T00:36:56.959Z
The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, it said | Economy | CNN
The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, the company said in a statement.
Learn more details here.
© Communities 2019 - Privacy
The information on this site is from external sources that are not under our control.